David Ledbetter | Executive Vice President and Chief Scientific Officer
Geisinger Health System

David Ledbetter, Executive Vice President and Chief Scientific Officer, Geisinger Health System

David H. Ledbetter, PhD, FACMG – is Executive Vice President and Chief Scientific Officer at Geisinger Health System, a large, not-for-profit integrated health system in Danville, PA. Dr. Ledbetter came to Geisinger from Emory University School of Medicine in Atlanta where he was the Robert W. Woodruff Professor and Director of the Division of Medical Genetics in the Department of Human Genetics. He previously held academic and leadership positions at the University of Chicago, the National Center for Human Genome Research (now NHGRI) at the National Institutes of Health and Baylor College of Medicine. He is a graduate of Tulane University and earned his doctorate at the University of Texas-Austin. After his early discovery of the genetic causes of Prader-Willi syndrome and then Miller-Dieker syndrome, Dr. Ledbetter has focused his research efforts on discovering the underlying etiology of childhood developmental disabilities such as autism, and the translation of new genomics technologies into clinically useful genetic tests for early diagnosis and intervention. His current research interest includes leveraging the massive amount of genomics data generated during routine patient care for knowledge generation and integration of this information into electronic health records in a clinically useful manner. Dr. Ledbetter has been a strong advocate of genomic data sharing to accelerate knowledge and improved patient care, and served as a plaintiff in the recent Supreme Court case, Association for Molecular Pathology v. Myriad Genetics (June 13, 2013), which overturned the patentability of human genes and will now allow increased access and improved quality of genetic testing in the United States.

back to speakers